baber/WOPTO huggingface dataset:
Patent NZ-211577-A (NZ)
Title: Sail with resilient transverse battens
Inventor: MAGNAN JEFFREY J
IPC: B64C31/02
Filed: 1985-03-26
Abstract: A flex wing apparatus comprising a support, a mast coupled to the support and a sail. Battens are carried by the sail, and a coupling arrangement joins the leading edge of the battens to the mast so that the sail and battens can pivot about the mast. The battens can be resiliently deformed varying magnitudes to induce the desired camber into the battens and the sail. The coupling arrangement includes couplings each of which includes a collar and a pair of resilient legs.
Patent NZ-215689-A (NZ)
Title: Hydrogen-absorbing composition and optical-fibre cables containing it
Inventor: SECCO A
IPC: C08K3/08
Filed: 1986-04-03
Abstract: This invention concerns a composition that is capable of chemically bonding, within itself, both large, or small quantities of hydrogen. 
<??>Once the composition, formed by a compound made of an unsaturated polymer, substantially a butadienic polymer and of a catalyst, is inserted into a cable containing opticalfibres, then the compound protects these from the effects of the hydrogen derived from any source whatsoever, also included are those opticalfibre cables, and opticalfibres cable-components which incorporate the compound in question.
Patent NZ-220398-A (NZ)
Title: A reagent for rendering biological media transparent and its use for analysis of these
Inventor: LINDEN GUY
IPC: G01N1/28
Filed: 1987-05-21
Abstract: The reagent of the invention consists of a combination of an aliphatic ketone, a detergent, a base and a denaturating agent for rendering transparent a protein and lipid containing mixture.
Patent NZ-227924-A (NZ)
Title: Removing hides from carcasses hanging by their fore and hind legs
Inventor: KJORUM ARNE
IPC: A22B5/16
Filed: 1989-02-09
Abstract: A method and a plant for pulling-off of the hide or skin of animal carcasses, wherein the plant forms part of a slaughtering line in a slaughterhouse. The carcasses are transported continuously on a transport path (23, 24) suspended from all four legs in an essentially horizontal position and with the longitudinal direction of the carcass in the movement direction of the transport path. In a lead-in area (1) of the path the rearward legs, as viewed in the transport direction, are retained in relation to the movement of the forward legs, and the carcass (9) thereafter is fed under tension with an essentially constant distance between the suspension points of the forward and rearward legs. After preflaying the hide/skin is pulled off by a stripper means, preferably a rotatable drum (91), which, in a stationary operative position below the back of the carcass (16), executes the stripping operation while the carcass (16) passes the stripper means (91).
Patent NZ-239646-A (NZ)
Title: Antimicrobial composition comprising octanoic acid or a derivative thereof
Inventor: RICHTER FRANCIS L
IPC: C11D3/20
Filed: 1991-09-03
Abstract: A food additive microbicidal composition consisting essentially of a major portion of carrier and an effective sanitizing amount of octanoic acid. Optionally, the invention may also consist essentially of any variety of formulatory ingredient options or application adjuvants. The invention comprises concentrate compositions and methods of sanitizing and disinfecting using the antimicrobial composition of the invention.
Patent NZ-244583-A (NZ)
Title: A compressed air pressure-tight resilient sealing arrangement for sealing valve ports to ducts has two seals: one of which has a tapered skirt portion
Inventor: ELLIOTT JEFF
IPC: F16L21/035
Filed: 1992-10-01
Abstract: PCT No. PCT/AU92/00532 Sec. 371 Date May 27, 1994 Sec. 102(e) Date May 27, 1994 PCT Filed Oct. 1, 1992 PCT Pub. No. WO93/07411 PCT Pub. Date Apr. 15, 1993A sealing and joining arrangement (49) suitable for use in conjunction with a valve (28) used for delivering a blast of compressed air from a reservoir (20) to a blow-tube (34) of a dust-collector baghouse (39). The arrangement comprises (i) a socket-to-tube interconnection including one seal (48) to adapt the socket to the tube; and (ii) a second compliant seal (42) to adapt either the socket or tube (as required) to a clearance hole (44) of a bulkhead wall (36) of the baghouse. The socket-to-tube part of the arrangement may be applied to either outlet (preferably), inlet or both. The arrangement (49) may facilitate assembly of many valves in a baghouse typical within the dust collector field.
Patent NZ-244764-A (NZ)
Title: Xylanase from rhodothermus marinus
Inventor: DAHLBERG LEIF ARNE LENNART
IPC: D21C5/00
Filed: 1992-10-16
Abstract: This invention relates to novel enzymes. More specifically, the invention provides novel xylanases obtainable from strains belonging to the genus Rhodothermus. The invention also relates to the use of the xylanases in the treatment of lignocellulosic pulp. <IMAGE>
Patent NZ-244981-A (NZ)
Title: Frangible two-chamber package for holding decontamination reagents; method of sterilizing medical instruments
Inventor: SIEGEL NORMAN L
IPC: A61L31/16
Filed: 1992-11-02
Abstract: A front door (B) of a countertop decontamination unit is opened to gain access to a chamber (10) for receiving a cartridge (C) containing items to be sterilized and a chamber (12) for receiving a two compartment powdered anti-microbial agent carrying cup (D). The cup includes an outer cup portion (60) and an inner cup portion (70) that have peripheral walls (62, 72) affixed together at flanges (64, 74) and abutting base walls (66, 76). At least one of the base walls has a domed portion (68) constructed of plastic, whose plastic resiliency functions as a spring to urge the base walls continuously into engagement. The inner and outer cup portions peripheral walls define an annular chamber (86) therebetween. Preferably, the inner peripheral wall is generally conical to reinforce the outer cup base wall to prevent it from collapsing on impact with a cutting blade (14). The inner wall has a longitudinally elongated recess (80) which interacts with a filling aperture (84) surrounded by a flange portion (82). The longitudinal recess and filling aperture are configured such that a filling tube (92) is selectively insertable through the filling aperture and along the recess for filling the annular compartment with a powdered reagent. A permeable sheet (102) is affixed to the second cup portion flange for sealing both compartments. <IMAGE>
Patent NZ-278061-A (NZ)
Title: Foldable indexing tab for files, index cards etc
Inventor: JUNG JURGEN
IPC: B42F21/02
Filed: 1994-12-23
Abstract: PCT No. PCT/EP94/04303 Sec. 371 Date Oct. 24, 1995 Sec. 102(e) Date Oct. 24, 1995 PCT Filed Dec. 23, 1994 PCT Pub. No. WO95/23069 PCT Pub. Date Aug. 31, 1995The invention concerns an array of tabs (3) projecting out beyond the edge (1) of the main surface (2) of files, card-index cards, etc., particularly tabs designed for written annotations. In order to provide variable-design tabs (3) which do not involve the loss of material, the invention proposes that the tab (3) is folded over to bring it out of the main surface area (2) of the file or card to expose an area down to the fold line (11).
Patent NZ-503096-A (NZ)
Title: Tetrahydro gamma-carbolines
Inventor: KENNIS LUDO EDMOND JOSEPHINE
IPC: A61P25/22
Filed: 1998-09-01
Abstract: Compounds of formula (I), a N-oxide form, a pharmaceutically acceptable addition salt or stereochemically isomeric form wherein; R1 is hydrogen, C1-6alkyl, aryl or C1-6alkyl substituted with aryl; R2 is each independently a halogen, hydroxy, C1-6alkyl, C1-6alkyloxy or nitro; N is 0, 1, 2 or 3; Alk is C1-6alkanediyl; D is a radical of formula (a), (b), (c), (d), (e) or (f) wherein; X each independently is O, S or NR12 R3 is hydrogen, C1-6alkyl, aryl or arylC1-6alkyl; R4 is hydrogen, C1-6alkyl, C1-6alkyloxy, C1-6alkylthio, amino, mono- or di(C1-6alkyl)amino or mono- or di(arylC1-6alkyl)amino; R5, R6, R7, R10, R11 and R12 each independently are hydrogen or C1-6alkyl R8 and R9 each independently are hydrogen, C1-6alkyl or aryl; or R4 and R5 taken together may from a bivalent radical -R4-R5- of formula (a-1), (a-2), (a-3), (a-4) or (a-5); wherein one or two hydrogen atom of said radicals (a-1) to (a-5) each independently may be replaced with halogen, C1-6alkyl, arylC1-6alkyl, trifluoromethyl, amino, hydroxy, C1-6alkyloxy or C1-10alkylcarbonyloxy; or where possible, two geminal hydrogen atoms my be replaced by C1-6alkylidene or arylC1-6alkylidene; or -R4-R5- may also be (a-6), (a-7), (a-8), (a-9), (a-10), (a-11), (a-12), (a-13) or (a-14); wherein one or where possible two or three hydrogen atoms in the radicals (a-6) to (a-14) each independently may be replaced by C1-6alkyl or aryl; and aryl is phenyl or phenyl substituted with halogen or C1-6alkyl. The tetrahydro g-carbolines produced are suitable for use in medicine.
Patent NZ-504076-A (NZ)
Title: A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
Inventor: ORMEROD ANTHONY DAVID
IPC: A61K47/12
Filed: 1998-11-05
Abstract: A topical formulation for the treatment of a dermatological condition which comprises: i)	An immunosuppressive macrolide selected from sirolimus, FK506, and SDZ ASM 981. ii)	A permeation modulator selected from an alkanoic acid and an alkenic acid provided that when the immunosuppressive macrolide is FK506 the permeation modulator is not oleic acid. The permeation modulator and the macrolide are present in relative amounts such that when a therapeutic amount is applied to the skin a minimal systemic effect is produced. Also described is the use of an immunosuppressive macrolide selected from sirolimus, FK506, and SDZ ASM 981 in the preparation of the topical formulation described above.
Patent NZ-507408-A (NZ)
Title: Scaffolding Bracket with through bore and two blind bores so that tubes are interconnected and separated between adjacent frames
Inventor: WHEATLEY CHRISTOPHER JOHN
IPC: E04G7/30
Filed: 2000-10-09
Abstract: A bracket for a scaffold frame member including a through aperture at a corner portion adapted to accommodate in use a tubing member extendable therethrough, at least two capped apertures substantially adjacent said through aperture, each having an end abutment adjusted to engage an end of a respective further said tubing member, the said capped apertures being so positioned as to in use provide a separation of the said tubing members in adjacent frame members.
Patent NZ-507540-A (NZ)
Title: Hyaluronic acid based imaging agents containing gadolinium or iron oxide
Inventor: KIDD GEORGE HARRISON
IPC: A61K49/18
Filed: 1999-04-27
Abstract: Imaging agents containing hyaluronic acid (HA) and gadolinium, optionally with liposomes, and HA complexed with superparamagnetic iron oxides are provided.   The imaging agents may be used in an imaging method to view tumour cells with magnetic resonance.
Patent NZ-514994-A (NZ)
Title: Food composition with high solids content, a method for its preparation as well as the use of carrageenans for gelling a food composition
Inventor: JONSSON TORBEN
IPC: A23L29/256
Filed: 2000-05-12
Abstract: A food composition comprising soluble solids in the range of about 50 % to about 90 % by weight, at least 70 % by weight thereof being a sweetening comprising sucrose and non sucrose sweeteners in a weight ratio of sucrose to non sucrose sweeteners of 0:100 to 95:5, wherein the non sucrose sweetener is of a DE (Dextrose Equivalent) of at least about 30, a carrageenan component in an amount sufficient to form a gel, and water to balance, and wherein the gelation temperature, determined as a Haake Rheometer, RS 100 using the settings û Gradient 1_C/min, 04640 Hz, 95_C - 65_C, t=1800 s, 0.50 Pa, 65_C - 35_C, t=1800 s, 2.50Pa, of the food composition is < 95_C. This food composition may be produced by a process comprising: (a) dispersing carrageenan in a syrup of a non sucrose sweetener at a temperature sufficient to disperse the carrageenan in said syrup while stirring; (b) adding water and heating the mixture to the boiling point thereof; (c) adjusting the soluble solids content to from about 50 % to about 90 % by weight, (d) depositing said mixture and (e) cooling said mixture to below the depositing temperature of said mixture. The food composition gels rapidly and forms a gel at temperatures of below 95_C. This food composition is especially confectionery products such as soft candies, marshmallows or glazings.
Patent NZ-515790-A (NZ)
Title: Packaging container, packaging body including the same, and packaging method
Inventor: IWASAKI YOSHIO
IPC: B65D1/34
Filed: 2001-03-19
Abstract: A tray which is capable of providing a sufficient bond strength  in an operation for thermobonding the tray  and  a stretch  film  by  an  inclined heat  roller.  A  tray  (10) comprises a bottom surface (11), a wall surface (12), and  a flange  (13).  The  bottom surface (11)  is  a  surface  for placing  an  object  to be packaged. The wall  surface  (12) extends upward from the bottom surface (11) to surround  the latter.  The flange (13) extends outward from the upper  end of  the  wall surface (12). Further, the flange (13)  has  a curved  portion  (13a)  on  the wall  surface  side  and  an inclined  portion (13b) positioned outwardly of  the  curved portion  (13a).  And  the  inclined  portion  (13b)  has   a substantially  linear cross section in  its  upper  surface. Further,  the curved portion (13a) is formed such  that  the wall  surface  (12) and the inclined portion  (13b)  form  a continuous shape.
Patent NZ-517826-A (NZ)
Title: Iodine containing antimicrobial compositions for mastitis control
Inventor: FREDELL DALE LIND
IPC: A61P31/04
Filed: 2000-09-19
Abstract: An antimicrobial composition comprising: (1) an iodine compound complexed with at least one non-ionic surfactant. (2) a C7-C9 fatty acid. (3) a carrier. Also described is a method for controlling mastitis in milk producing animals wherein the above composition is applied to a teat of the animal.
Patent NZ-521809-A (NZ)
Title: Leaf spring assembly having full leaf leaf spring component and half leaf leaf spring component
Inventor: WILSON WILLIAM
IPC: B60G11/02
Filed: 2001-02-23
Abstract: A leaf spring assembly for use as an active component in vehicle suspension systems includes a full-leaf leaf spring component and a half-leaf leaf spring component connected thereto. The full-leaf leaf spring extends substantially the entire length of the leaf spring assembly and the half-leaf leaf spring extends substantially the entire length of one of the cantilevers. In a preferred form, when the leaf spring assembly has front and rear cantilevers of substantially unequal length, the leaf spring assembly provides for a constant caster angle for its associated axle during deflection of the assembly due to jounce and rebound. In another preferred form, when the leaf spring assembly has front and rear cantilevers of substantially equal length, the leaf spring assembly provides for a varying caster angle for its associated axle during deflection of the assembly due to jounce and rebound. In yet another preferred form, the axle seat portion of the full-leaf leaf spring is designed such that it biases the position of the axle associated with the leaf spring assembly to a predetermined caster angle.
Patent NZ-522963-A (NZ)
Title: Methods and compositions using sulodexide for the treatment of diabetic nephropathy
Inventor: PALAZZINI ERNESTO
IPC: A61K31/70
Filed: 2001-06-06
Abstract: Disclosed is the use of Sulodexide for the preparation of a medicament for the treatment of diabetic nephropathy, wherein the medicament is in a unit dosage form comprising, per unit dosage, from about 200 mg (2000 LRU) to about 1000 mg (10,000 LRU) of Sulodexide, or a pharmaceutically acceptable salt thereof, wherein the medicament is adapted for oral administration.
Patent NZ-525140-A (NZ)
Title: Tweak receptor and Fn14 agonists as anti-angiogenic agents
Inventor: BROWNING JEFFREY
IPC: A61K39/395
Filed: 2001-09-12
Abstract: Described is the use of an anti-Fn14 antibody as an Fn14 agonist in the manufacture of a medicament for modulating angiogenesis and inhibiting tumor progression. The antibody can be used in combination with TWEAK or an anti-Fn14 monoclonal antibody. Also mentioned is the use of an Fn14-Fc fusion protein and the use of TWEAK or an anti-Fn14 antibody that agonizes Fn14 in the manufacture of a medicament to treat macular degeneration or diabetic retinopathy, wherein the TWEAK or anti-Fn14 antibody inhibits angiogenesis by the endothelial cells associated with pathogenesis of the inflammatory macular degeneration or diabetic retinopathy.
Patent NZ-527021-A (NZ)
Title: A composite insulator body having the rod coated by injection moulding
Inventor: LEVILLAIN ROGER
IPC: H01B17/00
Filed: 2003-07-15
Abstract: A method of manufacturing a composite electrical insulator constituted by a rod (2; 12) surrounded by an insulating coating (6; 16) and having metal fittings (4; 14) at both its ends is disclosed, wherein the method consists of the following steps: fixing two respective metal interfaces (3; 13) to the two ends of the rod, the metal end fittings of the insulator subsequently being fixed to the interface;and putting the coating into place around the rod and around the metal interfaces while leaving an end portion of each metal interface uncovered by the coating so as to enable the metal end fitting to be fixed thereto subsequently.
Patent NZ-528712-A (NZ)
Title: Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
Inventor: ALBERT RAINER
IPC: A61P31/18
Filed: 2002-04-08
Abstract: Described is a compound of formula (I), wherein X is a direct bond;-CH2-;-CH2-CH2-;-CHR9-;-C(O)-;-O-;-NH-or NR9; R1 is optionally R10 and/or R11-substituted phenyl; optionally R10 and/or R11 -substituted heteroaryl; optionally R10 and/or R11-substituted heteroaryl N-oxide; or optionally R10 and/or R11-substituted naphthyl; R2 has one of the significances given for R1; or is optionally R10 and/or R11-substituted fluorenyl; or optionally R10- substituted adamantyl; R3 has one of the significances given for R1; or is optionally R10 and/or R11-substituted fluorenyl; R10-substituted adamantyl; each of R4, independently, has one of the significances of R5; or is CN; OH; OR9; F; Cl; Br; or I; each of R5, independently, is H; C1-C6 alkyl; C1-C6 hydroxyalkyl; C2-C6 alkoxyalkyl; C1-C6 halogenoalkyl; phenyl; benzyl; or heteroaryl; each of R6, independently, has one of the significances given for R4; each of R7, independently, has one of the significances given for R5; R8 is H; C1-C6 alkyl; C2-C6 alkenyl; C2-C6 alkynyl; phenyl; benzyl; CN; CH2NH2; CH2NHR9; CH2NR9R9; CH2NHC(O)R9; CH2NR9C(O)R9; CH2NHC(O)NHR9; CH2NR9C(O)NHR9; CH2NR9C(O)NR9R9 ; CH2NHC(O)OR9; CH2NR9C(O)OR9; CH2NHSO2R9; CH2N(S02R9)2; or CH2NR9SO2R9; each R9, independently, is C1-C6 alkyl; C3-C6 cycloalkyl; C2-C6 alkenyl; C2-C6 alkynyl; phenyl; benzyl; heteroaryl; or CF3; R1O represents 1 to 4 substituents independently selected from C1-C6 alkyl ; C1-C6 hydroxyalkyl; C2-C6 alkoxyalkyl; C1- C6 halogenoalkyl; C1-C6 cycloalkyl; C2-C6 alkenyl; C3-C6 cycloalkenyl; C2-C6 alkynyl; phenyl; heteroaryl; heteroaryl N- oxide; F; Cl; Br; I; OH; OR9; CONH2; CONHR9; CONR9R9; OC(O)R9; OC(O)OR9; OC(O)NHR9; OC(O)NR9R9; OS02R9; COOH; COOR9; CF3; CHF2; CH2F; CN; NO2; NH2; NHR9; NR9R9; NHC(O)R9; NR9C(O)R9; NHC(O)NHR9; NHC(O)NH2; NR9C(O)NHR9; NR9C(O)NR9R9; NHC(O)OR9; NR9C(O)OR9; NHS02R9; N(S02R9)2; NR9SO2R9; SR9; S(O)R9; S02R9; Si(CH3)3 and B(OC(CH3)2)2; R11 represents two adjacent substituents which form an annulated 4-7 membered nonaromatic ring optionally containing up to two heteroatoms selected independently from N,O and S; and Y is a direct bond;-C(O)- ;-C (O) CH2- ;-S (O)- ;-S (02)- ;-C (S)-; -CH2- ;-C (-CH2-CH2-)- ;-CH (R5)- or-C (R4)2-, in free form or in salt form. The compound is described to be used as a chemokine inhibitor in the preparation of pharmaceutical compositions for preventing or treating acute or chronic rejection, autoimmune diseases, cancer or infectious diseases.
Patent NZ-529597-A (NZ)
Title: Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
Inventor: PEREZ CARL
IPC: A61K38/00
Filed: 2002-05-30
Abstract: Disclosed is a method of identifying plant genes comprising the following steps: Generating an artificial chromosome comprising euchromatic DNA from a first species of plant; Introducing the chromosome into a cell from a second species of plant; Detecting phenotypic changes in the plant cell comprising the artificial chromosome and/or a plant generated from the plant cell comprising the artificial chromosome; Wherein the artificial chromosome comprising euchromatic DNA from a first plant species is produced by a method comprising: Introducing into a plant cell of the first species of plant an artificial chromosome capable of undergoing homologous recombination with the DNA of the first species of plant; Selecting for a recombination event between the artificial chromosome and the DNA of the first species of plant; Selecting an artificial chromosome comprising euchromatic DNA from the first species of plant. The recombination may be site-specific recombination, and the artificial chromosome is preferably a plant or mammalian artificial chromosome, and methods for producing suitable acrocentric artificial plant chromosomes are included.
Patent NZ-532324-A (NZ)
Title: End portion for a flexible fluid containment vessel and a method of making the same
Inventor: DAVIS TRENT W
IPC: B63B35/28
Filed: 2002-10-24
Abstract: Here is provided a flexible fluid containment vessel fabricated out of a fabric for transporting and containing a large volume of fluid, particularly fresh water, having a tapered front and/or rear portions on which an end portion is affixed in the form of a clamping mechanism sealing the same.
Patent NZ-539889-A (NZ)
Title: Assembly for fastening a transportation device of a cableway system on a suspension bar
Inventor: SCHERTLER KURT
Filed: 2005-05-06
Abstract: An assembly for fastening a transportation device of a cableway system, such as a cabin or a chair, on a suspension bar, which is formed at its upper end with a running mechanism, with a coupling clamp, interacting with the conveying cable or traction cable of the cableway system, and with a guide roller, the transportation device also being provided at its upper end with a supporting device, by way of which it is articulated on the lower end of the suspension bar in a way allowing it to be pivoted transversely with respect to the conveying cable or traction cable. The articulation of the transportation device on the lower end of the suspension bar is formed by two links, which are located at a distance from each other transversely in relation to the conveying cable or traction cable and run obliquely upward in relation to each other, their free ends being articulated on the one hand on the supporting device and on the other hand on the lower end of the suspension bar.
Patent NZ-545787-A (NZ)
Title: 2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof
Inventor: LINDEN JOEL M
IPC: A61K31/4015
Filed: 2002-10-01
Abstract: Disclosed is a compound of formula (I), wherein: Z is NR4R5; X is ûCH2ORa, ûCO2Ra, ûOC(=O)Ra, ûCH2OC(=O)Ra, ûC(=O)NRaRb, ûCH2SRa, ûC(=S)ORa, ûOC(=S)Ra, ûCH2OC(=S)Ra, C(=S)NRaRb or ûCH2N(Ra)(Rb); and the remaining substituents are as defined in the specification; or a pharmaceutically acceptable salt thereof. The compounds have A2A adenosine receptor agonist activity and are useful in the manufacture of a medicament to inhibit an inflammatory response in a mammal.